These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1541816)

  • 1. Synthetic peptides of human CD4 enhance binding of Ig to monocyte/macrophage cells. I. Characterization and mapping studies.
    Lenert P; Mehta RL; Zanetti M
    J Immunol; 1992 Mar; 148(6):1759-63. PubMed ID: 1541816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic peptides of human CD4 enhance binding of immunoglobulins to monocyte/macrophage cells. II. Mechanisms of enhancement.
    Mehta RL; Lenert P; Zanetti M
    Cell Immunol; 1994 Jun; 156(1):146-54. PubMed ID: 8200032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal sequence requirements for synthetic peptides derived from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) to enhance HIV-1 binding to cells and infection.
    Zanotto C; Calderazzo F; Dettin M; Di Bello C; Autiero M; Guardiola J; Chieco-Bianchi L; De Rossi A
    Virology; 1995 Feb; 206(2):807-16. PubMed ID: 7856094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptides corresponding to CD4-interacting regions of murine MHC class II molecules modulate immune responses of CD4+ T lymphocytes in vitro and in vivo.
    Shen X; Hu B; McPhie P; Wu X; Fox A; Germain RN; König R
    J Immunol; 1996 Jul; 157(1):87-100. PubMed ID: 8683160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of HIV glycoprotein gp120 by T cells. Role of monocyte CD4 in the presentation of gp120.
    Siliciano RF; Knall C; Lawton T; Berman P; Gregory T; Reinherz EL
    J Immunol; 1989 Mar; 142(5):1506-11. PubMed ID: 2537355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule.
    Takeshita T; Takahashi H; Kozlowski S; Ahlers JD; Pendleton CD; Moore RL; Nakagawa Y; Yokomuro K; Fox BS; Margulies DH
    J Immunol; 1995 Feb; 154(4):1973-86. PubMed ID: 7530749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
    Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
    Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic CD4 exocyclic peptides antagonize CD4 holoreceptor binding and T cell activation.
    Zhang X; Piatier-Tonneau D; Auffray C; Murali R; Mahapatra A; Zhang F; Maier CC; Saragovi H; Greene MI
    Nat Biotechnol; 1996 Apr; 14(4):472-5. PubMed ID: 9630922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A site for CD4 binding in the beta 1 domain of the MHC class II protein HLA-DR1.
    Brogdon J; Eckels DD; Davies C; White S; Doyle C
    J Immunol; 1998 Nov; 161(10):5472-80. PubMed ID: 9820523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the interaction between focal adhesion kinase and CD4.
    Garron ML; Arthos J; Guichou JF; McNally J; Cicala C; Arold ST
    J Mol Biol; 2008 Feb; 375(5):1320-8. PubMed ID: 18078954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.
    Barbouche R; Decroly E; Kieny MP; Fenouillet E
    Virology; 2000 Jul; 273(1):169-77. PubMed ID: 10891419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR studies on the conformation of the CD4 36-59 peptide bound to HIV-1 gp120.
    Gizachew D; Moffett DB; Busse SC; Westler WM; Dratz EA; Teintze M
    Biochemistry; 1998 Jul; 37(30):10616-25. PubMed ID: 9692951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the site in CD4 that binds to the HIV envelope glycoprotein.
    Brodsky MH; Warton M; Myers RM; Littman DR
    J Immunol; 1990 Apr; 144(8):3078-86. PubMed ID: 1691226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.
    Trkola A; Dragic T; Arthos J; Binley JM; Olson WC; Allaway GP; Cheng-Mayer C; Robinson J; Maddon PJ; Moore JP
    Nature; 1996 Nov; 384(6605):184-7. PubMed ID: 8906796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the V3 loop involved in HIV binding to CD4?
    Dettin M; Ferranti P; Scarinci C; Picariello G; Di Bello C
    Biochemistry; 2003 Aug; 42(30):9007-12. PubMed ID: 12885233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthetic CD4 exocyclics inhibit binding of human immunodeficiency virus type 1 envelope to CD4 and virus replication in T lymphocytes.
    Zhang X; Gaubin M; Briant L; Srikantan V; Murali R; Saragovi U; Weiner D; Devaux C; Autiero M; Piatier-Tonneau D; Greene MI
    Nat Biotechnol; 1997 Feb; 15(2):150-4. PubMed ID: 9035140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
    Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
    J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence by peptide mapping that the region CD4(81-92) is involved in gp120/CD4 interaction leading to HIV infection and HIV-induced syncytium formation.
    Kalyanaraman VS; Rausch DM; Osborne J; Padgett M; Hwang KM; Lifson JD; Eiden LE
    J Immunol; 1990 Dec; 145(12):4072-8. PubMed ID: 1701782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purified beta-chain of MHC class II binds to CD4 molecules on transfected HeLa cells.
    Nag B; Wada HG; Passmore D; Clark BR; Sharma SD; McConnell HM
    J Immunol; 1993 Feb; 150(4):1358-64. PubMed ID: 8432982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.